COLL — Collegium Pharmaceutical Share News
0.000.00%
Last trade - 00:00- $765.06m
- $1.85bn
- $780.57m
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%
Brief: Collegium Completes Acquisition Of Azstarys® From Corium Therapeutics
Collegium Pharmaceutical Q1 revenue rises 9%, beats estimates
Collegium Pharmaceutical to acquire Corium's ADHD drug for up to $785 million
Collegium Q4 revenue up 13% but slightly misses estimates
U.S. RESEARCH ROUNDUP-Ardelyx, RPM International, Trubridge
Collegium Pharma beats Q3 revenue estimates, raises guidance
Brief: Paris Hilton Collaborates With Collegium Pharmaceutical To Share Her Personal Adhd Journey And Experience With Treatment
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Pharma Q2 revenue beats analyst expectations
Brief: Collegium Announces $25 Million Accelerated Share Repurchase Program
Collegium Pharmaceutical Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board
Brief: Collegium Announces Updates To Its Board Of Directors And Executive Leadership Team
Collegium Pharmaceutical Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Collegium Provides 2025 Financial Guidance And Business Update